Antibody-mediated regulation of cellular immunity and the inflammatory response.
about
Toll-like receptors and B-cell receptors synergize to induce immunoglobulin class-switch DNA recombination: relevance to microbial antibody responsesA human monoclonal immunoglobulin M reduces bacteremia and inflammation in a mouse model of systemic pneumococcal infectionCross-presentation of IgG-containing immune complexesPeripheral blood and pleural fluid mononuclear cell responses to low-molecular-mass secretory polypeptides of Mycobacterium tuberculosis in human models of immunity to tuberculosis.Antibody-mediated protection against Cryptococcus neoformans pulmonary infection is dependent on B cellsVaccination with recombinant N-terminal domain of Als1p improves survival during murine disseminated candidiasis by enhancing cell-mediated, not humoral, immunity.Detection of antibody-dependent complement-mediated inactivation of both autologous and heterologous virus in primary human immunodeficiency virus type 1 infection.The absence of serum IgM enhances the susceptibility of mice to pulmonary challenge with Cryptococcus neoformans.Differential expression of immunogenic proteins on virulent Mycobacterium tuberculosis clinical isolates.Dynamic antibody responses to the Mycobacterium tuberculosis proteomeAntibody to Cryptococcus neoformans glucuronoxylomannan inhibits the release of capsular antigenHistopathological Study of the Lungs of Mice Receiving Human Secretory IgA and Challenged with Mycobacterium tuberculosisApplying Convergent Immunity to Innovative Vaccines Targeting Staphylococcus aureus.Using an agent-based model to analyze the dynamic communication network of the immune response.Modulation of polymorphonuclear cell interleukin-8 secretion by human monoclonal antibodies to type 8 pneumococcal capsular polysaccharideSynthesis and Evaluation of Protein Conjugates of GM3 Derivatives Carrying Modified Sialic Acids as Highly Immunogenic Cancer Vaccine CandidatesPreparation and immunological studies of protein conjugates of N -acylneuraminic acids.Synthesis and immunological properties of N-modified GM3 antigens as therapeutic cancer vaccines.The Ebola epidemic crystallizes the potential of passive antibody therapy for infectious diseases.Passive antibody therapy for infectious diseases.New concepts in antibody-mediated immunity.Does Circulating Antibody Play a Role in the Protection of Piglets against Porcine Epidemic Diarrhea Virus?Antibody-mediated immunomodulation: a strategy to improve host responses against microbial antigensImmunogenicity and efficacy of Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan peptide mimotope-protein conjugates in human immunoglobulin transgenic mice.The potential of antibody-mediated immunity in the defence against biological weapons.Opinion: antibody-based therapies for malaria.The Basic Immune Simulator: an agent-based model to study the interactions between innate and adaptive immunityProtective and destructive immunity in the periodontium: Part 1--innate and humoral immunity and the periodontium.Protective and nonprotective human immunoglobulin M monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan manifest different specificities and gene use profiles.Protective efficacy of the chimeric Staphylococcus aureus vaccine candidate IC in sepsis and pneumonia modelsA new synthesis for antibody-mediated immunity.Improving the antigenicity of sTn antigen by modification of its sialic acid residue for development of glycoconjugate cancer vaccinesSynthetic glycopeptide vaccines combining beta-mannan and peptide epitopes induce protection against candidiasis.Anti-infective antibodies: a novel tool to prevent and treat nosocomial diseases.Regulatory B cells in autoimmune diseases and mucosal immune homeostasisPassive immunization of neonatal mice against Pneumocystis carinii f. sp. muris enhances control of infection without stimulating inflammation.Recent advances in developing synthetic carbohydrate-based vaccines for cancer immunotherapies.Immunoglobulins in defense, pathogenesis, and therapy of fungal diseases.AIM/CD5L: a key protein in the control of immune homeostasis and inflammatory disease.Synthesis and Evaluation of Glycoconjugates Comprising N-Acyl-Modified Thomsen-Friedenreich Antigens as Anticancer Vaccines.
P2860
Q24624348-AAEAA6FE-6704-4DC9-86EB-AD720679B143Q24672825-D2B3EEEA-7A75-47B0-B8B0-E8A5CCDB64ADQ26825801-B62C9234-62D7-479A-A155-907E1010B0AFQ33788061-CFC77498-0870-4803-A76D-4D4109076866Q33793546-A8B30722-B7BF-4829-94B1-AC469E608169Q33798458-E049DFAF-1DE0-454D-B324-C39C557FD459Q33834852-5D4B42AB-2C95-485C-8911-9ABCBCB897ECQ33912345-2E6F744F-BB17-45B1-80E1-05C0F5624D8CQ33943428-9006A08C-68C4-4CC3-847B-E734EB30DAF9Q34093311-9AF627AF-8952-485E-8EC1-798F5D6DDBAFQ34146715-C2C05376-70CB-457A-AA55-8E725DCAE55DQ34178105-F30331E4-0BD0-482F-A8F7-D58611A1F055Q34250054-9F3775D9-2B04-4C0F-97F0-ADD5451D923EQ34547306-490B4B95-3F4A-41F3-93E1-861CA786919DQ34940688-4F767BA9-8C51-45C0-AA3D-183A56CFD4A3Q35212122-C1D20C34-76BB-4E6C-B097-16B7A0AF40B1Q35228550-C351B1C7-8571-472F-8971-9C1F54CC8456Q35234194-F919AAD2-E465-4981-9E53-98DC66B54F07Q35532972-458FBA97-CD8F-4EBD-A90D-87825E1FB571Q35889582-F2AD07C2-AAB5-460E-8F75-A85819D13904Q35926507-993356CA-1318-4219-AC68-F2220FAD15B2Q35981194-18C70591-BC8D-4D58-8D00-F99F3CAD6D17Q36017488-43589A77-25FC-4F3E-A678-06F1E9F6021FQ36228216-E2B7AAE3-F213-4930-BFC6-826B94E82C50Q36273411-1D4A78BF-96E8-4CF2-9256-9D04534709B9Q36302325-554161BF-4747-449E-8E99-203468D2A5E7Q36345148-1428D138-3852-4B0D-94C0-ACC76DA6B053Q36404749-8DF60C8A-E7B7-48F9-B55B-39AC0968E3C3Q36446429-9DB636BC-1A80-45FB-839B-471B7A5FA788Q36569841-1480BF3B-682B-4312-B311-C8588BD4F53AQ36660720-8E97709C-BAD5-4B37-9982-6AB00FFB45D1Q36868822-C1D34A55-349A-4932-9A96-B41510B0FA49Q36869958-9B0D5577-9204-42E2-96F3-66248EDBF740Q37077611-39A6EC77-B3E0-4EF6-806A-CC9A41FCB497Q37095181-66CF3B91-57FB-4E23-94B2-FCE188B77CCEQ37582861-6B2F7B1B-7D56-47DC-BEF0-3759B8DF2682Q37993590-7B4C8B9C-FEBB-4E1A-9CAE-812B87431D63Q38011299-15BB8D88-59BA-4942-BF5A-A5ECDFDAB202Q38517909-062424C0-56CD-445E-8F14-7AF1B081686DQ38778469-294364C6-785A-4CE9-BAB1-E9FBE5392921
P2860
Antibody-mediated regulation of cellular immunity and the inflammatory response.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Antibody-mediated regulation of cellular immunity and the inflammatory response.
@ast
Antibody-mediated regulation of cellular immunity and the inflammatory response.
@en
type
label
Antibody-mediated regulation of cellular immunity and the inflammatory response.
@ast
Antibody-mediated regulation of cellular immunity and the inflammatory response.
@en
prefLabel
Antibody-mediated regulation of cellular immunity and the inflammatory response.
@ast
Antibody-mediated regulation of cellular immunity and the inflammatory response.
@en
P1433
P1476
Antibody-mediated regulation of cellular immunity and the inflammatory response.
@en
P304
P356
10.1016/S1471-4906(03)00228-X
P577
2003-09-01T00:00:00Z